Cargando…

The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill

Because medical illness is associated with increased inflammation and an increased risk for treatment-resistant major depressive disorder, anti-cytokine therapy may represent a novel, and especially efficacious, treatment for depression. We hypothesized that blockade of the interleukin (IL)-6 signal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knight, Jennifer M., Costanzo, Erin S., Singh, Suraj, Yin, Ziyan, Szabo, Aniko, Pawar, Deepa S., Hillard, Cecilia J., Rizzo, J. Douglas, D’Souza, Anita, Pasquini, Marcelo, Coe, Christopher L., Irwin, Michael R., Raison, Charles L., Drobyski, William R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812704/ https://www.ncbi.nlm.nih.gov/pubmed/33462203 http://dx.doi.org/10.1038/s41398-020-01164-y

Ejemplares similares

The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation
por: Taylor, Mallory R., et al.
Publicado: (2022)

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease
por: Drobyski, William R., et al.
Publicado: (2018)

Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination
por: Chhabra, Saurabh, et al.
Publicado: (2022)

DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation
por: Dhakal, B., et al.
Publicado: (2016)

Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial
por: D'Souza, Anita, et al.
Publicado: (2020)

Interleukin-9 production by type 2 innate lymphoid cells induces Paneth cell metaplasia and small intestinal remodeling
por: Yuan, Chengyin, et al.
Publicado: (2023)

Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study
por: Knight, Jennifer M., et al.
Publicado: (2015)

Serum Concentrations of the Endocannabinoid, 2-Arachidonoylglycerol, in the Peri-Trauma Period Are Positively Associated with Chronic Pain Months Later
por: Trevino, Colleen M., et al.
Publicado: (2022)

Blood and Marrow Transplantation (BMT) within Four Weeks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study
por: Mohan, Meera, et al.
Publicado: (2022)

Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
por: Hammons, Lindsay R., et al.
Publicado: (2022)

Worse and Worse and Worse: Essential Tremor Patients’ Longitudinal Perspectives on Their Condition
por: Gutierrez, Jesús, et al.
Publicado: (2016)

Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
por: Marfella, R., et al.
Publicado: (2020)

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
por: Woxholt, Sindre, et al.
Publicado: (2023)

Cannabinoids: for better and for worse 
por: Thibaut, Florence, et al.
Publicado: (2020)

Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease
por: Piper, Clint, et al.
Publicado: (2019)

Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease
por: Rayasam, Aditya, et al.
Publicado: (2021)

Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
por: Herold, Zoltan, et al.
Publicado: (2020)

Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19
por: Szabo, Robert, et al.
Publicado: (2023)

Evaluation of tradipitant, a selective NK1 antagonist, on response to oxycodone in humans
por: Coe, Marion A., et al.
Publicado: (2021)

The Role of Regulatory T Cells in the Biology of Graft Versus Host Disease
por: Beres, Amy J., et al.
Publicado: (2013)

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
por: Zhang, Chi, et al.
Publicado: (2020)

Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab
por: Donnelly, Jonathan P., et al.
Publicado: (2021)

‘Everything was just getting worse and worse’: deteriorating job quality as a driver of doctor emigration from Ireland
por: Humphries, N., et al.
Publicado: (2019)

LIFE COURSE PATHWAYS OF CHILDHOOD SOCIOECONOMIC STATUS TOWARD CLINICAL RISK FACTORS FOR WORSE KIDNEY FUNCTION
por: Surachman, Agus, et al.
Publicado: (2019)

Getting Worse
Publicado: (1857)

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
por: Frigault, Matthew J., et al.
Publicado: (2020)

Cytokine responses across submaximal exercise intensities in women with major depressive disorder
por: Perez, Maria L., et al.
Publicado: (2020)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Associations between socioeconomic status and bispecific LV20.19 CAR T-cell therapy outcomes
por: Knight, Jennifer M., et al.
Publicado: (2022)

Tuberculosis sepsis after tocilizumab treatment
por: Reisinger, A.C., et al.
Publicado: (2020)

Tocilizumab and COVID-19: Timing of administration assessment
por: Richier, Q., et al.
Publicado: (2022)

Interleukin-6 Antagonist Tocilizumab to Treat Critically Ill Coronavirus Disease 2019 Patients With Cytokine Release Syndrome: A Case Series
por: Yang, Stephen Su, et al.
Publicado: (2021)

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
por: Yu, Su-Yeon, et al.
Publicado: (2022)

High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Is the Patient Getting Worse?
por: Singh, Kuldev
Publicado: (2009)

Confusion worse confounded
por: Noronha, Vanita, et al.
Publicado: (2013)

Confusion Worse Confounded
Publicado: (1891)

Confusion Worse Confounded
Publicado: (1890)

Confusion Worse Confounded
Publicado: (1907)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_va472lqp33jj27jk7dgdbasfsq